Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110.KQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$15.01B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xcell Therapeutics, Inc.Xcell Therapeutics, Inc.-1.2--272%31.2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$15.01 Billion
Enterprise Value$16.47 Billion
Earnings per Share$-938
Beta1.3
Outstanding Shares17,294,000

Return

Return on Equity-271.80%ROE
Return on Assets-93.12%
Return on Invested Capital-162.23%

Valuation & Multiples

P/E Ratio-1.2P/E Ratio
PEG-3.72PEG
Price to Sales2.95Price to Sales
Price to Book Ratio3.47Price to Book Ratio
Enterprise Value to Revenue3.23
Enterprise Value to EBIT-1.36
Enterprise Value to Net Income-2
Total Debt to Enterprise0.33
Debt to Equity1.24Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Xcell Therapeutics, Inc.

65 employees
CEO: Uri Lee

Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a...